Alvotech announces increase in number of own shares

Alvotech (nasdaq: alvo) (the “company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, has increased the company´s share capital by an amount of one hundred and thirty thousand (usd 130,000) by issuing thirteen million (13,000,000) ordinary shares. the company's subsidiary, alvotech manco ehf. (the “subsidiary”), has subscribed to all of the newly issued shares for a price of usd 15.98 per share. the shares held by the subsidiary are treated as treasury shares without voting rights or dividend entitlement.
ALVO Ratings Summary
ALVO Quant Ranking